Glenn Allen Redelman is a notable inventor based in Morgantown, WV (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of various dosage forms. With a total of 4 patents to his name, Redelman continues to push the boundaries of innovation in drug delivery systems.

Latest Patents

One of Redelman's latest patents focuses on a fenofibrate formulation. This innovative dosage form includes a plurality of beads or particles that contain a pharmaceutical composition comprising fenofibrate, a surfactant, and a water-soluble or water-dispersible cellulosic binder. The mass ratio of the drug to the binder is carefully calibrated to enhance the drug's bioavailability, producing a first Cmax in vivo that is significantly higher than that of comparative dosage forms. Another notable patent involves liquid-filled hard gel capsule pharmaceutical formulations. This formulation comprises a non-emulsified mixture that includes an active pharmaceutical ingredient, medium chain triglycerides, and medium chain mono/diglycerides, all in specific weight ratios to optimize efficacy.

Career Highlights

Glenn Allen Redelman is currently associated with Mylan GmbH, a leading global pharmaceutical company. His work at Mylan has allowed him to develop innovative solutions that address various medical needs. His expertise in pharmaceutical formulations has made him a valuable asset to the company.

Collaborations

Throughout his career, Redelman has collaborated with several talented individuals, including Sarat C Chattaraj and Andrew Alan Shaw. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical technologies.

Conclusion

Glenn Allen Redelman is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact in the industry. His innovative approaches to drug delivery continue to enhance patient care and treatment outcomes.

Profile summary based on public USPTO records.